BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32092817)

  • 1. MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway.
    Hua B; Li Y; Yang X; Niu X; Zhao Y; Zhu X
    Biomed Pharmacother; 2020 May; 125():109994. PubMed ID: 32092817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
    Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
    Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53.
    Abdolvahabi Z; Nourbakhsh M; Hosseinkhani S; Hesari Z; Alipour M; Jafarzadeh M; Ghorbanhosseini SS; Seiri P; Yousefi Z; Yarahmadi S; Golpour P
    J Cell Biochem; 2019 Jun; 120(6):9356-9368. PubMed ID: 30520099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer.
    Zheng Y; Zheng Y; Lei W; Xiang L; Chen M
    Mol Cell Probes; 2019 Dec; 48():101445. PubMed ID: 31513891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspongopus chinensis ach-miR-276a-3p induces breast cancer cell cycle arrest by targeting APPL2 to regulate the CDK2-Rb-E2F1 signaling pathway.
    Cai R; Khan S; Chen X; Li H; Tan J; Tian Y; Zhao S; Yin Z; Liu T; Jin D; Guo J
    Toxicol Appl Pharmacol; 2024 Mar; 484():116877. PubMed ID: 38431228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
    Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y
    Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T; Song Y; Yu H; Luo X
    Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
    Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; Pützer BM
    Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.
    Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z
    J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.
    Zhao M; Zhang M; Tao Z; Cao J; Wang L; Hu X
    Technol Cancer Res Treat; 2020; 19():1533033820905824. PubMed ID: 32174262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis.
    Zhang D; Yang XJ; Luo QD; Xue L; Chong T
    Cancer Gene Ther; 2022 Jul; 29(7):1001-1011. PubMed ID: 34799723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.
    Wang GP; Mou ZL; Xu YY; Liu GX; Wang DM; Zhang HP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7445-7456. PubMed ID: 31539132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-1258 Regulates Cell Proliferation and Cell Cycle to Inhibit the Progression of Breast Cancer by Targeting E2F1.
    Zhao X
    Biomed Res Int; 2020; 2020():1480819. PubMed ID: 32733928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-329-3p suppresses proliferation and metastasis of endometrial carcinoma through downregulating E2F1.
    Wang R; Zhang C; Guan W; Yang Q
    Neoplasma; 2023 Aug; 70(4):566-579. PubMed ID: 37789781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.
    Xia XY; Yu YJ; Ye F; Peng GY; Li YJ; Zhou XM
    Neoplasma; 2020 Mar; 67(2):344-353. PubMed ID: 31973537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F1-Induced FTH1P3 Promoted Cell Viability and Glycolysis Through miR-377-3p/LDHA Axis in Laryngeal Squamous Cell Carcinoma.
    Zhao L; Zheng Y; Zhang L; Su L
    Cancer Biother Radiopharm; 2022 May; 37(4):276-286. PubMed ID: 33571038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.